Qiagen Teams with Max Planck on TB MDx Test
January 09, 2012
Qiagen Teams with Max Planck on TB MDx Test
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Qiagen Expands Companion Dx Portfolio with Three Licensing Deals; Exceeds 2012 QiaSymphony Placement Target
January 7, 2013 / GenomeWeb Daily News - Qiagen, Max Planck Developing qPCR-Based Test for Active TB Risk in Latently Infected Patients
January 12, 2012 / PCR Insider - Revising Molecular Dx Roadmap, Qiagen Will Migrate PCR Tests Across Automated Platforms
May 12, 2011 / PCR Insider - Alere Garners Up to $42.2M in Grants and Loans from Gates Foundation for POC MDx Platforms
March 1, 2013 / GenomeWeb Daily News - Qiagen Q4, 2012 Growth Driven Significantly by QiaSymphony Sales in MDx, Applied Markets
January 31, 2013 / PCR Insider